2013 annual financial data
Sarepta Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -454.99%.
Operating income was -90,284,000 USD and net income was -111,985,000 USD.
Operating cash flow was -64,695,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,219,000 USD
- Operating income
- -90,284,000 USD
- Net income
- -111,985,000 USD
- Operating cash flow
- -64,695,000 USD